Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control
Karen Canfell, Jane J. Kim, Shalini Kulasingam, et al.
Papillomavirus Research (2019) Vol. 8, pp. 100184-100184
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries
Marc Brisson, Jane J. Kim, Karen Canfell, et al.
The Lancet (2020) Vol. 395, Iss. 10224, pp. 575-590
Open Access | Times Cited: 637
Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries
Karen Canfell, Jane J. Kim, Marc Brisson, et al.
The Lancet (2020) Vol. 395, Iss. 10224, pp. 591-603
Open Access | Times Cited: 442
Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study
Kate T. Simms, Sharon J. B. Hanley, Megan A. Smith, et al.
The Lancet Public Health (2020) Vol. 5, Iss. 4, pp. e223-e234
Open Access | Times Cited: 180
Domestic HPV vaccine price and economic returns for cervical cancer prevention in China: a cost-effectiveness analysis
Zhuoru Zou, Christopher K. Fairley, Jason J. Ong, et al.
The Lancet Global Health (2020) Vol. 8, Iss. 10, pp. e1335-e1344
Open Access | Times Cited: 124
Projected time to elimination of cervical cancer in the USA: a comparative modelling study
Emily A. Burger, Megan A. Smith, James Killen, et al.
The Lancet Public Health (2020) Vol. 5, Iss. 4, pp. e213-e222
Open Access | Times Cited: 84
Cost-effectiveness studies of HPV self-sampling: A systematic review
Colin C. Malone, Ruanne V. Barnabas, Diana S. M. Buist, et al.
Preventive Medicine (2020) Vol. 132, pp. 105953-105953
Open Access | Times Cited: 74
Review of human papillomavirus (HPV) burden and HPV vaccination for gay, bisexual, and other men who have sex with men and transgender women in the United States
Elissa Meites, Timothy Wilkin, Lauri E. Markowitz
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 1
Open Access | Times Cited: 48
Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population
Kate T. Simms, Adam Keane, Diep Nguyen, et al.
Nature Medicine (2023) Vol. 29, Iss. 12, pp. 3050-3058
Open Access | Times Cited: 39
Cost-effectiveness of artificial intelligence-assisted liquid-based cytology testing for cervical cancer screening in China
Mingwang Shen, Zhuoru Zou, Heling Bao, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 34, pp. 100726-100726
Open Access | Times Cited: 22
Estimated Cancer Risk in Females Who Meet the Criteria to Exit Cervical Cancer Screening
Shalini Kulasingam, Inge M.C.M. de Kok, Abhinav Mehta, et al.
JAMA Network Open (2025) Vol. 8, Iss. 3, pp. e250479-e250479
Open Access | Times Cited: 1
Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis
Jane J. Kim, Kate T. Simms, James Killen, et al.
PLoS Medicine (2021) Vol. 18, Iss. 3, pp. e1003534-e1003534
Open Access | Times Cited: 43
Evidence-based impact projections of single-dose human papillomavirus vaccination in India: a modelling study
Irene Man, Damien Georges, Tiago M. de Carvalho, et al.
The Lancet Oncology (2022) Vol. 23, Iss. 11, pp. 1419-1429
Open Access | Times Cited: 36
Potential population-level effectiveness of one-dose HPV vaccination in low-income and middle-income countries: a mathematical modelling analysis
Élodie Bénard, Mélanie Drolet, Jean‐François Laprise, et al.
The Lancet Public Health (2023) Vol. 8, Iss. 10, pp. e788-e799
Open Access | Times Cited: 21
Health and economic impact of delaying large-scale HPV vaccination and screening implementation on cervical cancer in China: a modelling study
Meng Gao, Shangying Hu, Xuelian Zhao, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 36, pp. 100768-100768
Open Access | Times Cited: 15
Methodological Approaches for Incorporating Marginalized Populations into HPV Vaccine Modeling: A Systematic Review
Jennifer C. Spencer, Juan Yanguela, Lisa P. Spees, et al.
Medical Decision Making (2025)
Closed Access
Could HPV Testing on Self-collected Samples Be Routinely Used in an Organized Cervical Screening Program? A Modeled Analysis
Megan A. Smith, Michaela Hall, Marion Saville, et al.
Cancer Epidemiology Biomarkers & Prevention (2020) Vol. 30, Iss. 2, pp. 268-277
Open Access | Times Cited: 29
Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV
Michaela Hall, Kate T. Simms, John M. Murray, et al.
Nature Medicine (2023) Vol. 29, Iss. 12, pp. 3059-3066
Open Access | Times Cited: 10
Building resilient cervical cancer prevention through gender-neutral HPV vaccination
Irene Man, Damien Georges, Rengaswamy Sankaranarayanan, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 9
The cost-effectiveness profile of sex-neutral HPV immunisation in European tender-based settings: a model-based assessment
Venetia Qendri, Johannes A. Bogaards, Iacopo Baussano, et al.
The Lancet Public Health (2020) Vol. 5, Iss. 11, pp. e592-e603
Open Access | Times Cited: 22
Optimal allocation strategies for HPV vaccination introduction and expansion in China accommodated to different supply and dose schedule scenarios: a modelling study
Tingting You, Xuelian Zhao, Shangying Hu, et al.
EClinicalMedicine (2022) Vol. 56, pp. 101789-101789
Open Access | Times Cited: 12
Health and economic effects of introducing single-dose or two-dose human papillomavirus vaccination in India
T. M. de Carvalho, Irene Man, Damien Georges, et al.
BMJ Global Health (2023) Vol. 8, Iss. 11, pp. e012580-e012580
Open Access | Times Cited: 7
Upper age limits for US male human papillomavirus vaccination for oropharyngeal cancer prevention: a microsimulation-based modeling study
Rebecca Landy, Gregory Haber, Barry I. Graubard, et al.
JNCI Journal of the National Cancer Institute (2023) Vol. 115, Iss. 4, pp. 429-436
Open Access | Times Cited: 6
Modeling Infectious Diseases in Healthcare Network (MInD-Healthcare) Framework for Describing and Reporting Multidrug-resistant Organism and Healthcare-Associated Infections Agent-based Modeling Methods
Rachel B. Slayton, Justin J. O’Hagan, Sean Barnes, et al.
Clinical Infectious Diseases (2020) Vol. 71, Iss. 9, pp. 2527-2532
Open Access | Times Cited: 16
The road to cervical cancer elimination in Malaysia: Evaluation of the impact and cost‐effectiveness of human papillomavirus screening with self‐collection and digital registry support
Adam Keane, Chiu‐Wan Ng, Kate T. Simms, et al.
International Journal of Cancer (2021) Vol. 149, Iss. 12, pp. 1997-2009
Open Access | Times Cited: 15
The cost-effectiveness of human papillomavirus self-collection among cervical cancer screening non-attenders in El Salvador
Nicole G. Campos, Karla Alfaro, Mauricio Maza, et al.
Preventive Medicine (2019) Vol. 131, pp. 105931-105931
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top